Neoadjuvant Imatinib in a gastrointestinal stromal tumor of the rectum: Report of a case

Surgery Today

Volumn 38, Issue 2, 2008, Pages 174-177

  Ebihara, Yuma ^a   Okushiba, Shunichi ^a   Kawarada, You ^a   Kitashiro, Shuji ^a   Katoh, Hiroyuki ^a   Kondo, Satoshi ^b  

^a Tonan Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coloanal anastomosis; Gastrointestinal stromal tumor; Imatinib; Laparoscopic ultralow anterior resection

Indexed keywords

IMATINIB; STEM CELL FACTOR RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LABORATORY TEST; RECTUM TUMOR; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; COLECTOMY; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LAPAROSCOPY; MIDDLE AGED; NEOADJUVANT THERAPY; PIPERAZINES; PYRIMIDINES; RECTAL NEOPLASMS;

EID: 38849207468     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3585-6     Document Type: Article

References (10)

1. Meijer S, Peretz T, Gaynor JJ, Tan C, Hajdu SI, Brennan MF. Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg 1990;125:1163-1168.
2. Markku M, Mary F, Maarit SR, Allen B, Leslie HS, Jerzy L. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. Am J Surg Pathol 2001;25:1121-1133.
3. Tworek JA, Goldblum JR, Weiss SW, Greenson JK, Appelman HD. Stromal tumors of the anorectum: a clinicopathologic study of 22 cases. Am J Surg Pathol 1999;23:946-954.
4. Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumours. Br J Surg 2003;90:1178-1186.
5. Hama Y, Okizuka H, Odajima K, Hayakawa M, Kusano S. Gastrointestinal stromal tumor of the rectum. Eur Radiol 2001;11: 2016-2019.
6. Shibata Y, Tadashi U, Seki H, Yagihashi N. Gastrointestinal stromal tumor of the rectum. Eur J Gastroenterol Hepatol 2001;13: 283-286.
7. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-734.
8. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-1056.
9. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480.
10. Wu PC, Langerman A, Ryan CW, Hart J, Swiger S, Posner MC. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003;13:656-665.